In contrast, treatment with the synthetic AIM2 inflammasome ligand poly(dA:dT) did not inhibit RhoA-GTP activity in any of the genotypes tested (Extended Data Fig. 5d, e), suggesting that infection has a distinct ability to integrate the AIM2-mediated signaling and RhoA signaling cascades to influence Pyrin activation. Here, AIM2 is linked to infection.